GlassScriptPhysician profile
Abena Larbi
NPI 1861277303
$3,379.35
in general payments reported to CMS, 2019-2025
15 companies · $2,174 in 2025
The $2,174 reported for 2025 was more than what 95% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,205 · 2025: $2,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784 · Travel and Lodging: $1,595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,784.29 |
| Travel and Lodging | $1,595.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $1,404.15 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $583.22 | 2024-2025 | Evoke |
| Abbvie INC. | $334.01 | 2024-2025 | |
| Boston Scientific Corporation | $283.03 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Biotronik Nro, INC. | $222.63 | 2025 | Prospera |
| Collegium Pharmaceutical, INC. | $129.87 | 2024-2025 | Belbuca |
| Tersera Therapeutics LLC | $111.35 | 2024-2025 | Prialt |
| Averitas Pharma INC. | $87.69 | 2024-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $71.51 | 2024-2025 | |
| Valinor Pharma, LLC | $35.63 | 2025 | Movantik |
| Scilex Pharmaceuticals INC. | $30.19 | 2025 | |
| Medtronic, INC. | $27.50 | 2024 | Synchromedii |
| Foundation Fusion Solutions, LLC | $26.28 | 2025 | |
| Si-Bone, INC. | $16.99 | 2024 | |
| Lundbeck LLC | $15.30 | 2024 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abena Larbi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.